A baby, referred to as Baby KJ, is reportedly the world's first patient to receive a personalized CRISPR therapy. The development of individualized therapies for rare diseases may be accelerating, with the FDA possibly launching a framework for such treatments. CNBC has also launched an initiative, CNBC Cures, which aims to help those with rare diseases, a group estimated to number around 30 million Americans.